Del(6)(q22) and BCL6 Rearrangements in Primary CNS Lymphoma Are Indicators of an Aggressive Clinical Course

PURPOSE: Primary CNS lymphoma (PCNSL) is an aggressive lymphoma but clinically validated biologic markers that can predict natural history to tailor treatment according to risk are lacking. Several genetic changes including BCL6 rearrangements and deletion of 6q22, containing the putative tumor supp...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Cady, Francois M., O'Neill, Brian Patrick, Law, Mark E., Decker, Paul A., Kurtz, David M., Giannini, Caterina, Porter, Alyx B., Kurtin, Paul J., Johnston, Patrick B., Dogan, Ahmet, Remstein, Ellen D.
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Clinical Oncology 2008
Assuntos:
Lymphoma and Myeloma
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2653136/
https://ncbi.nlm.nih.gov/pubmed/18645192
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2008.16.1455
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares